Predictors of hepatocellular carcinoma recurrence associated with the use of direct ‐acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study

ConclusionsA high AFP level and multiple occurrences of HCC before DAA therapy are associated with a high risk for HCC recurrence after curative treatment. Follow ‐up after DAA therapy should include special attention to the abovementioned risk factors.

Source: Cancer Medicine - March 21, 2019 Category: Cancer & Oncology Authors: Masahito Nakano, Hironori Koga, Tatsuya Ide, Ryoko Kuromatsu, Satoru Hashimoto, Hiroshi Yatsuhashi, Masataka Seike, Nobito Higuchi, Makoto Nakamuta, Satoshi Shakado, Shotaro Sakisaka, Satoshi Miuma, Kazuhiko Nakao, Yoko Yoshimaru, Yutaka Sas Tags: ORIGINAL RESEARCH Source Type: research